** Barclays initiates Springer Nature SPGG.DE with
"overweight" rating saying the German publishing group's stock
offers good value and exposure to resilient industry
** "Academic Publishing is one of the most resilient
industries we have come across, with organic growth not dipping
negative in any of the recent major downturns," the brokerage
says
** It adds the stock's valuation of 14x P/E and 10.8x
EV/EBITDA on 2025 is "looking good" as the broker expects about
7% FCF and adjusted EPS growth going forward
** Barclays notes that Springer Nature's core journals
business has a long track record of growth delivery, and low
level of competition
** It notes an overhang risk from BC Partners, which has
36% stake, but adds that improving liquidity can help the story
over time
** Out of eight analysts that cover Springer Nature, all
rate the stock "strong buy" or "buy"
(Reporting by Anastasiia Kozlova)
((Anastasiia.Kozlova@thomsonreuters.com))